NCT06317038

Brief Summary

To evaluate the performance of Total 30® (lehfilcon A) contact lenses in patients using digital devices for greater than 8 hours per day 5 days per week based on subjective reported data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 19, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

March 31, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2024

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

May 1, 2025

Status Verified

April 1, 2025

Enrollment Period

8 months

First QC Date

March 12, 2024

Last Update Submit

April 29, 2025

Conditions

Keywords

Contact lensesDigital DevicesEye Comfort

Outcome Measures

Primary Outcomes (1)

  • Likert question about comfort satisfaction while wearing Total 30 contact lenses on a typical day (> 13 hours of daily wear) after 1 month of wear and heavy digital device usage (>8 hours daily wear).

    Likert Questionaire: Strongly Disagree, Disagree, Neither Agree nor Disagree, Agree, Strongly Agree

    1 month

Secondary Outcomes (3)

  • Likert responses to insertion comfort and overall vision, and heavy digital device use on a typical day after 1 month of wear.

    1 month

  • Results of subjective ratings of patients using Total 30 lenses and heavy digital device usage with VAS diary questionnaire.

    1 month

  • Report on total daily wear time and digital device usage.

    1 month

Study Arms (1)

Digital Device uses for 8 hours per day

OTHER

Observational responses from patients using digital devices for 8 hours per day will be given a monthly Total 30 Contact lens.

Device: Total 30 Contact Lens

Interventions

Patients will be give a contact lens for 1 month

Digital Device uses for 8 hours per day

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients aged 18-40 of any sex and any race.
  • Reports habitually using digital device usage (phone, Ipad, computer, social media, video streaming) for 8 hours or more per day 5 days per week with plans to continue the habit throughout the study.
  • Wearing contact lenses for at least 13 hours daily 5 days per week.
  • Spherical refractive error between -11.00 D and +6.00D with \< -0.75 D of astigmatism.
  • Willing to comply with the protocol instructions.
  • Has read (or has had read to), understood, and signed an Informed Consent.
  • Willing to not use any artificial tears, rewetting drops or dry eye treatments during the study.

You may not qualify if:

  • Active ocular infection or ocular inflammatory disease.
  • Presbyopic or pre-presbyopic that have a measured add power for reading.
  • Current Total 30 contact lens wearer.
  • Anterior basement membrane dystrophy or history of recurrent erosion syndrome or topographical abnormalities that might indicate ectasia or other corneal degenerative conditions.
  • Current or previous diagnosis of dry eye disease; currently using a dry eye treatment including but not limited to artificial tears, rewetting drops or prescription treatments.
  • History of severe / serious ocular pathology or other medical conditions that could result in an inability to safely complete the study.
  • Participation by the patient in any other investigational study within the past 30 days.
  • Unlikely to comply with protocol instructions for any reason (confusion, substance abuse, etc.). The Principal Investigator or the Medical Monitor reserves the right to declare a patient ineligible based on medical evidence that indicates the patient is unsuitable for the study.
  • Inability to utilize Clear Care Cleaning solution.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tauber Eye Center

Kansas City, Missouri, 64111, United States

Location

MeSH Terms

Conditions

Asthenopia

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Open label Observation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Crystal Remington OD, FAAO

Study Record Dates

First Submitted

March 12, 2024

First Posted

March 19, 2024

Study Start

March 31, 2024

Primary Completion

November 11, 2024

Study Completion

December 1, 2024

Last Updated

May 1, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared.

Locations